A molecularly identified P2Y receptor simultaneously activates phospholipase C and inhibits adenylyl cyclase and is nonselectively activated by all nucleoside triphosphates

Molecular Pharmacology

Volumn 57, Issue 4, 2000, Pages 805-810

  Boyer, José L ^a   Delaney, Suzanne M ^a   Villanueva, Demetrio ^a   Harden, T Kendall ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; CYCLIC AMP; CYTIDINE TRIPHOSPHATE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE; NUCLEOSIDE TRIPHOSPHATE; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE; XANTHOSINE 5' TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; ASTROCYTOMA CELL; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034074488     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.57.4.805     Document Type: Article

References (31)

1. Anderson CM and Parkinson FE (1997) Potential signalling roles for UTP and UDP: Sources, regulation and release of uracil nucleotides. Trends Pharmacol Sci 18: 387-392.
2. Bogdanov YD, Dale L, King BF, Whittock N and Burnstock G (1997) Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos. J Biol Chem 272:12583-12590.
3. 4 nucleotide receptor. Br J Pharmacol 124:428-430.
4. 2Y-purinergic receptor that inhibits adenylyl cyclase. J Pharmacol Exp Ther 267:1140-1146.
5. 2Y-purinergic receptors. Br J Pharmacol 116:2611-2616.
6. 1-receptor. Mol Pharmacol 50:1323-1329.
7. 2Y-purinoceptor agonists that are derivatives of adenosine 5′-monophosphate. Br J Pharmacol 118:1956-1964.
8. Boyer JL, Waldo GL and Harden TK (1997) Molecular cloning and expression of an avian G-protein coupled P2Y receptor. Mol Pharmacol 52:928-934.
9. 2Y-purinergic receptors. Br J Pharmacol 113:614-620.
10. Communi D, Govaerts C, Parmentier M and Boeynaems J-M (1997) Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 272:31969-31973.
11. Connolly GP, Demaine C and Duley JA (1998) Ecto-nucleotidases in isolated intact rat vagi, nodose ganglia, and superior cervical ganglia. Adv Exp Med Biol 431: 769-776.
12. Cooper DMF and Rodbell M (1979) ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase. Nature (Lond) 282:517-518.
13. Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith JB and Kunapuli SP (1998) Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 273:2024-2029.
14. Enomoto K, Furuya K, Yamagishi S, Oka T and Maeno T (1994) The increase in the intracellular Ca2+ concentration induced by mechanical stimulation is propagated via release of pyrophosphorylated nucleotides in mammary epithelial cells. Pflugers Arch 427:533-542.
15. 1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors. Br J Pharmacol 124:157-164.
16. Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U and Williams M (1997) Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci 18:79-82.
17. Gaarder A, Jonsen A, Laland S, Hellem AJ and Owen P (1961) Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature (Lond) 192:531-532.
18. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
19. 2-purinergic receptors: Subtype-associated signaling responses and structure. Annu Rev Pharmacol Toxicol 35: 541-579.
20. Harden TK, Lazarowski ER and Boucher RC (1997) Release, metabolism and interconversion of adenine and uridine nucleotides: Implications for G protein-coupled P2 receptor agonist selectivity. Trends Pharmacol Sci 18:43-46.
21. Harden TK, Scheer AG and Smith MM (1982) Differential modification of the interaction of cardiac muscarinic cholinergic and β-adrenergic receptors with a guanine nucleotide binding component(s). Mol Pharmacol 21:570-580.
22. Hourani SMO and Cusack NJ (1991) Pharmacological receptors on blood platelets. Pharmacol Rev 43:243-298.
23. 4 receptors. Br J Pharmacol 126:21P.
24. 11 receptor to phospholipase C and adenylyl cyclase. Br J Pharmacol 126:22P.
25. King BF, Townsend-Nicholson A and Burnstock G (1998) Metabotropic receptors for ATP and UTP: Exploring the correspondence between native and recombinant nucleotide receptors. Trends Pharmacol Sci 19:506-514.
26. Lazarowski ER and Harden TK (1999) Quantitaten of extracellular UTP using a sensitive enzymatic assay. Br J Pharmacol 127:1272-1278.
27. Lazarowski ER, Homolya L, Boucher RC and Harden TK (1997) Direct demonstration of mechanically induced release of cellular UTP and its implication for uridine nucleotide receptor activation. J Biol Chem 272:24348-24354.
28. Mellwig KP and Jakobs KH (1980) Inhibition of platelet adenylate cyclase by ADP. Thromb Res 18:7-17.
29. 1 receptor. Mol Pharmacol 54:1118-1123.
30. 1 receptor to phospholipase C. Br J Pharmacol 122:1021-1024.
31. 4 receptor. J Neurochem 71:1348-1357.